Taking the recently approved medicine dabigatran could mean a slightly higher risk compared with the drug warfarin, a study suggests.
People who take the recently approved blood-thinning medication dabigatran could have a slightly increased risk of heart attack compared with people who use the old standby drug warfarin, new research suggests.
